Most popular PerkinElmer appoints new chief market

  • Detail

PerkinElmer appoints new chief marketing officer

lapo Paladini is appointed to the newly established senior leadership position

Waltham, Massachusetts, July 27, 2009 (U.S. business) - PerkinElmer, Inc. (nyse:pki), a leading global company focused on improving the health and safety of human beings and their living environment, Today, we announced the appointment of Dr. LaPO Paladini as chief marketing officer (newly established position) and senior vice president

the newly established position of chief marketing officer will be responsible for leading PerkinElmer's marketing organization, and formulating and implementing key parts of the company's long-term marketing strategy, including marketing and channel strategies, and company communication. In the two published articles

"the newly established CMO position is a key component of the market-oriented approach in the field of human and environmental health," said Robert Friel, chairman and CEO of PerkinElmer, Inc. "We are pleased to receive LaPO's profound knowledge and insight into the needs of many different markets in the world, especially in the Asia Pacific and South American markets recently, to promote our marketing strategy and increase our business in high growth regions."

prior to this new appointment, Paladini served as president of PerkinElmer Asia Pacific, Eastern Europe, the Middle East, and Africa and South America. Since joining PerkinElmer in February, 1982, when the extrudate was completely converted from processing resin to cleaning resin, he immediately shut down and removed the die head. He has held a series of management positions in the company, including Vice President and general manager of European sales and service business of PerkinElmer analytical instruments, and head of global sales and marketing of PerkinElmer life and analytical sciences

Paladini holds a doctorate in industrial chemistry from the University of Pisa, Italy

about PerkinElmer, Inc.

PerkinElmer, Inc. is a global leading company focused on improving the health and safety of human beings and their living environment. It is reported that the company's revenue in 2008 was about $2billion, with about 8500 employees, providing services to customers in more than 150 countries/regions, and the company is also a member of the S & P 500 index. For additional information, please visit or call -pki-nyse

factors affecting future performance

the forward-looking statements contained in this draft are issued in accordance with the relevant provisions of the United States Private Securities Litigation amendment act of 1995, including but not limited to statements related to the prediction and estimation of future earnings, cash flow and income growth per share and other financial results Development related to our customers and final market and plans related to enterprise development opportunities

"believe", "intention", "expect", "plan", "expect", "expect", "expect", "will" and other words and similar expressions can be used as the basis for judging forward-looking statements. Such statements are based on the current assumptions and expectations of the management, and we cannot guarantee that all assumptions or expectations are completely correct. Many important risk factors may cause the actual results to differ significantly from the results described, implied or expected in any forward-looking statements. These factors include but are not limited to: (1) the sales market of our products is shrinking or does not reach the expected development level; (2) Global economic, political and other risks; (3) The company fails to launch new products in time; (4) The ability to acquire and obtain licensed technology, or the ability to successfully integrate the acquired business and licensed technology into the company's existing business or make profits from it; (5) Failing to fully protect the intellectual property rights of the company; (6) The company loses any license or license right; (7) The ability of the company to compete strongly; Weight reduction can shorten the braking distance (8) the company's quarterly operation results fluctuate and the ability to adjust the company's operation to solve unexpected accidents; (9) The supply of third-party software packages and import/export services are significantly interrupted or the price of the above services is greatly increased; (10) The supply of raw materials, important components and supplies is interrupted; (11) Manufacturing and selling products may subject us to product claims; (12) Failure to strictly comply with applicable government regulations; (13) Changes in regulations; (14) Fail to meet the requirements of

regulations in the health care industry; (15) Economic, political and other risks related to external operations; (16) Ability to maintain employment relationship with important personnel; (17) Major failure of information technology system or failure of successful implementation of new system; (18) Restrictions in the company's credit agreement; (19) The ability to recognize the full value of intangible assets; (20) Significant changes in stock prices; (21) our dividends may be reduced or cancelled in the future; And (22) other factors, which are described under the heading of "risk factors" in the latest annual statement 10-K and in the files we provided to the U.S. Securities and Exchange Commission. After this draft is issued, the company waives its intention and obligation to update any forward-looking statements on the progress that has occurred

note: the reprinted content is indicated with the source. The reprint is for the purpose of transmitting more information, and does not mean to agree with its views or confirm the authenticity of its content

Copyright © 2011 JIN SHI